The table below shows Caris Life Sciences, Inc.'s cash flow statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
Operating cash flow
$83.16M
-$245.20M
-$276.10M
Capital expenditure
$16.26M
$8.44M
$22.32M
Investing cash flow
-$16.26M
$52.93M
$214.77M
Dividends paid
-
-
-
Stock buybacks
$113.00K
$0.00
$0.00
Financing cash flow
$664.99M
$200.29M
$10.13M
CAI operating cash flow (10-K history)
Caris Life Sciences, Inc. reported operating cash flow of $83.16M for fiscal year 2025. That is up 133.9% from -$245.20M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
